Ascidian Therapeutics
Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.
| Company Details | |
|---|---|
| Title | Ascidian Therapeutics |
| Industries | Biotechnology, Genetics, Medical, Therapeutics |
| Headquarters Regions | Greater Boston Area, East Coast, New England |
| Headquarters Location | Boston, Massachusetts, United States |
| No Of Employees | 11-50 |
| Operating Status | Active |
Description
Ascidian Therapeutics is redefining the treatment of disease by rewriting RNA. By editing exons at the RNA level, Ascidian therapies enable precise post-transcriptional editing of genes, resulting in full-length, functional proteins at the right levels, in the right cells, at the right time. With active discovery and preclinical programs in ophthalmology, neurological and neuromuscular disorders, and other rare diseases, Ascidian is opening new therapeutic possibilities for patients in need of breakthroughs.